- Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc
Yi-Fei Wu et al, 2017, Biomedicine & Pharmacotherapy CrossRef - The transient receptor potential vanilloid-3 regulates hypoxia-mediated pulmonary artery smooth muscle cells proliferation via PI3K/AKT signaling pathway.
Qianlong Zhang et al, 2018, Cell Prolif CrossRef - Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7
Ji Hoon Jung et al, 2018, Oncogene CrossRef - Emerging roles of Myc in stem cell biology and novel tumor therapies.
Go J Yoshida, 2018, J Exp Clin Cancer Res CrossRef - FBW7 Regulates the Autophagy Signal in Mesangial Cells Induced by High Glucose
Chenlin Gao et al, 2019, BioMed Research International CrossRef - FBXW7 Mutations Promote Cell Proliferation, Migration, and Invasion in Cervical Cancer.
Faying Liu et al, 2019, Genet Test Mol Biomarkers CrossRef - Loss of Fbxw7 synergizes with activated AKT signaling to promote c-Myc dependent cholangiocarcinogenesis
Jingxiao Wang et al, 2019, Journal of Hepatology CrossRef - High WDR34 mRNA expression as a potential prognostic biomarker in patients with breast cancer as determined by integrated bioinformatics analysis
Dao‑Jun Hu et al, 2019, Oncol Lett CrossRef - The promotional effect of microRNA-103a-3p in cervical cancer cells by regulating the ubiquitin ligase FBXW7 function
Li Ren et al, 2022, Human Cell CrossRef - TRPV3 promotes the angiogenesis through HIF-1α-VEGF signaling pathway in A549 cells
Xiaolei Li et al, 2022, Acta Histochemica CrossRef - Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming et al, 2023, J Hematol Oncol CrossRef - miR‑25‑3p serves as an oncogenic in colorectal cancer cells by regulating the ubiquitin ligase FBXW7 function
Yanbin Chen et al, 2024, Oncol Rep CrossRef - FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects
Wanqing Wang et al, 2024, Front. Pharmacol. CrossRef